A study published in the journal Breast Cancer Research and Treatment has found that women overwhelmingly reject the breast cancer prevention drug tamoxifen even when given a thorough, personalized analysis of its risks and benefits. University of Michigan researchers administered the information about the drug to 632 women and found that only one percent of participants actually ended up taking it.

Originally formulated to prevent recurrences in women who have already had breast cancer, tamoxifen is now being touted as a breast cancer prevention drug.

The women who participated in the study were given detailed information about how the drug would work for them based on a number of personalized factors. These included medical and family history, age, and race. After completion, only 29 percent of women said they would research the drug further. A mere six percent said they were likely to actually take tamoxifen.

Following the study, of the 29 percent who said they would seek out more information about tamoxifen, only six percent actually did. Among those who said they were likely to take it, a measly one percent followed through.

Eighty-percent of the women who participated in the study indicated that they were most concerned about the side effects of the drug, which include sexual problems, hot flashes, blood clots, cataracts, and endometrial cancer. Despite concern among some that women are not taking the drug because they don't know about it, Dr. Peter Ubel from the University of Michigan noted that the real reason women are not taking tamoxifen is because of the many dangers associated with it.

This is a fascinating study because it shows that when women are properly informed about the dangers of cancer drugs, they almost universally reject them.

This is why the cancer industry works so hard to keep women ignorant by distancing them from accurate information about the dangers of chemotherapy, radiation, surgery and anti-cancer drugs. The more women know about these things, the more they reject conventional cancer treatments altogether (and the more they seek out alternative therapies).

Alternative (natural) therapies are non-toxic, safe, affordable and highly effective at both preventing and treating cancer.

Sources for this story include:
http://www2.med.umich.edu/prmc/medi...





Nearly 100 percent of women reject tamoxifen drug despite claims that it prevents breast cancer
Tuesday, December 22, 2009
by Mike Adams, the Health Ranger